Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 8/20 | 0.73 |
| ▸ | VDR | P11473 | 4/20 | 0.73 |
| ▸ | CASP7 | P55210 | 3/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.73 |
| ▸ | USP2 | O75604 | 3/20 | 0.73 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.73 |
| ▸ | TP53 | P04637 | 2/20 | 0.73 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.73 |
| ▸ | BLM | P54132 | 2/20 | 0.73 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.73 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.73 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.73 |
| ▸ | MDM4 | O15151 | 1/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.73 |
| ▸ | MAPT | P10636 | 1/20 | 0.73 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5577551 | 1.00 | GPBAR1 (0.73) | GPBAR1VDRCASP7HSD17B10TDP1 | |
| SCHEMBL11525625 | 0.92 | GPBAR1 (0.62) | GPBAR1VDRCASP7HSD17B10TDP1 | |
| SCHEMBL11525628 | 0.92 | GPBAR1 (0.62) | GPBAR1VDRCASP7HSD17B10TDP1 | |
| SCHEMBL235607 | 0.89 | GPBAR1 (0.77) | GPBAR1VDRCASP7HSD17B10TDP1 | |
| SCHEMBL235606 | 0.89 | GPBAR1 (0.77) | GPBAR1VDRCASP7HSD17B10TDP1 | |
| SCHEMBL26670009 | 0.89 | GPBAR1 (0.77) | GPBAR1VDRCASP7HSD17B10TDP1 | |
| SCHEMBL1697152 | 0.88 | GPBAR1 (0.76) | GPBAR1VDRCASP7HSD17B10TDP1 | |
| SCHEMBL1697153 | 0.88 | GPBAR1 (0.76) | GPBAR1VDRCASP7HSD17B10TDP1 | |
| SCHEMBL11530923 | 0.88 | GPBAR1 (0.56) | GPBAR1VDRCASP7HSD17B10TDP1 | |
| SCHEMBL8568004 | 0.87 | GPBAR1 (0.61) | GPBAR1VDRCASP7HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113314402-B | Photoresist composition and method for manufacturing semiconductor device | 台湾积体电路制造股份有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119439628-A | Photoresist composition and method for forming photoresist pattern and patterning material layer | 台湾积体电路制造股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-113311661-B | Photoresist underlayer composition and method for manufacturing semiconductor device | 台湾积体电路制造股份有限公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-113805435-B | Photoresist and method | 台湾积体电路制造股份有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-117420728-A | Method for manufacturing semiconductor device and photoresist composition | 台湾积体电路制造股份有限公司 | 2024-01-19 | — | — | CN | disclosed |
| CN-111123643-B | Protective composition and method for forming photoresist pattern | 台湾积体电路制造股份有限公司 | 2023-11-07 | — | — | CN | disclosed |
| US-20070179100-A1 | Protected monomers | ALNYLAM PHARMACEUTICALS, INC. | 2007-08-02 | — | — | US | disclosed |
| EP-1625138-A2 | PROTECTED MONOMERS | Alnylam Pharmaceuticals Inc. (US) | 2006-02-15 | — | — | EP | disclosed |
| WO-2004094345-A2 | PROTECTED MONOMERS | ALNYLAM PHARMACEUTICALS INC. (US) | 2004-11-04 | — | — | WO | disclosed |
| US-4145357-A | STEROID DERIVATIVES AND PROCESS FOR PREPARING THE SAME | CHUGAI SYIYAKU KABUSHIKI KAISHA (JP) | 1979-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070179100-A1 | Protected monomers | PCNA, POLN, PARP1 | GPBAR1 4124/4885VDR 4209/4885CASP7 1410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.